Two Sigma Advisers’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-45,600
| Closed | -$18.9M | – | 2474 |
|
|
2024
Q4 | $18.9M | Buy |
45,600
+11,600
| +34% | +$5.09M | 0.04% | 332 |
|
|
2024
Q3 | $17.2M | Buy |
34,000
+33,300
| +4,757% | +$16.2M | 0.04% | 350 |
|
|
2024
Q2 | $341K | Hold |
700
| – | – | ﹤0.01% | 2017 |
|
|
2024
Q1 | $378K | Buy |
700
+100
| +17% | +$54.6K | ﹤0.01% | 1984 |
|
|
2023
Q4 | $333K | Sell |
600
-13,900
| -96% | -$6.53M | ﹤0.01% | 2073 |
|
|
2023
Q3 | $6.34M | Buy |
+14,500
| New | +$7.23M | 0.02% | 633 |
|
|
2022
Q4 | – | Sell |
-12,700
| Closed | -$4.14M | – | 2603 |
|
|
2022
Q3 | $4.14M | Sell |
12,700
-4,400
| -26% | -$1.62M | 0.01% | 829 |
|
|
2022
Q2 | $6M | Buy |
17,100
+6,500
| +61% | +$2.65M | 0.02% | 691 |
|
|
2022
Q1 | $5.8M | Buy |
10,600
+3,900
| +58% | +$2.05M | 0.02% | 741 |
|
|
2021
Q4 | $4.41M | Buy |
+6,700
| New | +$4.21M | 0.01% | 820 |
|
|
2021
Q3 | – | Sell |
-3,100
| Closed | -$1.96M | – | 2543 |
|
|
2021
Q2 | $1.96M | Sell |
3,100
-5,592
| -64% | -$3.09M | 0.01% | 1309 |
|
|
2021
Q1 | $4.25M | Buy |
+8,692
| New | +$4.35M | 0.01% | 917 |
|
|
2020
Q4 | – | Sell |
-7,492
| Closed | -$2.94M | – | 2481 |
|
|
2020
Q3 | $2.94M | Sell |
7,492
-52,800
| -88% | -$19.5M | 0.01% | 974 |
|
|
2020
Q2 | $19.9M | Sell |
60,292
-187,800
| -76% | -$54.4M | 0.06% | 329 |
|
|
2020
Q1 | $60.1M | Buy |
248,092
+163,100
| +192% | +$42.6M | 0.23% | 104 |
|
|
2019
Q4 | $22.2M | Buy |
84,992
+62,084
| +271% | +$16.4M | 0.05% | 359 |
|
|
2019
Q3 | $6.23M | Sell |
22,908
-13,250
| -37% | -$3.69M | 0.02% | 690 |
|
|
2019
Q2 | $9.96M | Sell |
36,158
-40,400
| -53% | -$9.95M | 0.02% | 586 |
|
|
2019
Q1 | $17.1M | Sell |
76,558
-69,700
| -48% | -$14.4M | 0.04% | 449 |
|
|
2018
Q4 | $27.2M | Sell |
146,258
-163,100
| -53% | -$33.4M | 0.07% | 309 |
|
|
2018
Q3 | $77.2M | Sell |
309,358
-200,100
| -39% | -$48.6M | 0.19% | 146 |
|
|
2018
Q2 | $111M | Sell |
509,458
-47,000
| -8% | -$9.68M | 0.3% | 78 |
|
|
2018
Q1 | $107M | Buy |
556,458
+63,200
| +13% | +$11.7M | 0.29% | 86 |
|
|
2017
Q4 | $77.1M | Sell |
493,258
-78,400
| -14% | -$12.3M | 0.21% | 130 |
|
|
2017
Q3 | $88.9M | Sell |
571,658
-46,500
| -8% | -$7.35M | 0.25% | 106 |
|
|
2017
Q2 | $99.8M | Buy |
618,158
+12,090
| +2% | +$1.96M | 0.33% | 69 |
|
|
2017
Q1 | $93.7M | Buy |
606,068
+432,102
| +248% | +$59.6M | 0.31% | 77 |
|
|
2016
Q4 | $20.4M | Sell |
173,966
-39,154
| -18% | -$4.47M | 0.08% | 290 |
|
|
2016
Q3 | $24M | Buy |
213,120
+6,900
| +3% | +$727K | 0.1% | 224 |
|
|
2016
Q2 | $19.1M | Buy |
206,220
+159,600
| +342% | +$13.7M | 0.1% | 237 |
|
|
2016
Q1 | $3.65M | Buy |
+46,620
| New | +$3.36M | 0.02% | 602 |
|
|
2015
Q1 | – | Sell |
-6,120
| Closed | -$454K | – | 2124 |
|
|
2014
Q4 | $454K | Buy |
+6,120
| New | +$429K | ﹤0.01% | 1679 |
|
|
2014
Q1 | – | Sell |
-25,920
| Closed | -$1.38M | – | 2385 |
|
|
2013
Q4 | $1.38M | Buy |
+25,920
| New | +$1.36M | 0.01% | 961 |
|
Other funds holding IDXX
Two Sigma Advisers's IDXX Position: Q1 2025 in Review
Two Sigma Advisers sold out of Idexx Laboratories (IDXX) in Q1 2025, closing a stake of 45,600 shares — an estimated $18.9M sold.
Two Sigma Advisers first reported a position in IDXX in Q4 2013 and held it in 33 quarters. The position peaked at $111M in Q2 2018. 1,142 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.
- Two Sigma Advisers reported no remaining Idexx Laboratories position as of Q1 2025 after selling out during the quarter.
- Two Sigma Advisers sold 45,600 Idexx Laboratories shares in Q1 2025, an estimated $18.9M.
- Two Sigma Advisers first reported a position in Idexx Laboratories in Q4 2013 and held it in 33 quarters.
- Two Sigma Advisers's Idexx Laboratories position peaked at $111M in Q2 2018.
- 1,142 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.
Based on Two Sigma Advisers's 13F filing for Q1 2025, filed 15 May 2025.